Madison, WI, United States of America

Daniel Cullen



Average Co-Inventor Count = 5.0

ph-index = 5

Forward Citations = 162(Granted Patents)


Company Filing History:


Years Active: 1994-2002

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: The Innovations of Daniel Cullen

Introduction

Daniel Cullen is an accomplished inventor based in Madison, WI (US). He has made significant contributions to the field of biotechnology, particularly in the area of polypeptide expression using filamentous fungi. With a total of 6 patents to his name, Cullen's work has advanced the understanding and application of genetic engineering techniques.

Latest Patents

Cullen's latest patents focus on the development of novel vectors for expressing and secreting heterologous polypeptides from filamentous fungi. These vectors are designed to transform filamentous fungi, allowing them to express and secrete specific polypeptides. The vectors include a DNA sequence encoding the heterologous polypeptide and a signal sequence that is functional within the secretory system of the filamentous fungus. This innovative approach enables the efficient synthesis and secretion of valuable proteins, which can have various applications in biotechnology and pharmaceuticals.

Career Highlights

Cullen has been a key figure at Genencor International, Inc., where he has applied his expertise in genetic engineering to develop cutting-edge biotechnological solutions. His work has not only contributed to the company's success but has also positioned him as a leader in the field of biotechnology.

Collaborations

Throughout his career, Cullen has collaborated with notable colleagues, including Randy M Berka and Gregory Lawrence Gray. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Daniel Cullen's contributions to biotechnology through his innovative patents and collaborative efforts have made a lasting impact on the field. His work continues to inspire advancements in genetic engineering and the development of new biotechnological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…